Oncology Clinical Trials in Las Vegas, NV
As of September 2026, 60 paid clinical trials are recruiting for Oncology in Las Vegas, Nevada. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
60 clinical trials for Oncology
·Clear filters·Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
GEMINI-NSCLC: NSCLC Biomarker Study
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Top Research Study Locations in Las Vegas
Researchers run research studies in Las Vegas, NV at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| OptumCare Cancer Care at Charleston | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 47 |
| OptumCare Cancer Care at Fort Apache | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 45 |
| Comprehensive Cancer Centers of Nevada | Breast Cancer, Gastroesophageal Junction Adenocarcinoma, Malignant Solid Neoplasm | 40 |
| Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 40 |
| Summerlin Hospital Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | 36 |
| University Medical Center of Southern Nevada | Malignant Solid Neoplasm, Osteosarcoma, Acute Lymphoblastic Leukemia | 30 |
| Sunrise Hospital and Medical Center | Malignant Solid Neoplasm, Osteosarcoma, Acute Lymphoblastic Leukemia | 25 |
| Comprehensive Cancer Centers of Nevada - Central Valley | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 24 |
| Comprehensive Cancer Centers of Nevada - Northwest | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| Comprehensive Cancer Centers of Nevada - Town Center | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| Comprehensive Cancer Centers of Nevada-Summerlin | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| OptumCare Cancer Care at MountainView | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| Radiation Oncology Centers of Nevada Central | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| Radiation Oncology Centers of Nevada Southeast | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 21 |
| Hope Cancer Care of Nevada | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 20 |
| Urology Specialists of Nevada - Northwest | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 20 |
| Urology Specialists of Nevada - Southwest | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 20 |
| Urology Specialists of Nevada - Central | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 19 |
| Women's Cancer Center of Nevada | Recurrent Endometrial Carcinoma, Endometrial Cancer, Endometrial Clear Cell Adenocarcinoma | 16 |
| Oncology Las Vegas - Tenaya | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 14 |
| Vector Clinical Trials | Obesity, Overweight, Crohn Disease | 12 |
| Excel Clinical Research | Acute Migraine, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease | 10 |
| Redbird Research | Major Depressive Disorder, Alzheimer Disease, Acute Migraine | 10 |
| Las Vegas Prostate Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 9 |
| Las Vegas Urology - Cathedral Rock | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 9 |
Active & Upcoming Studies in Las Vegas (2026)
Recruiting trials in Las Vegas grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (100 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer · Phase 3 · J-Pharma Co., Ltd.
Diabetes & metabolic (45 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
Neurology & pain (31 active studies)
- An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD) · Phase 2 · Yale University
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Mental health & behavior (18 active studies)
- A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers · RAI Services Company
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
Cardiovascular (13 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- Mobile Dual-Task Brain and Balance Intervention for Concussion Recovery · Hyunhwa Lee
Vaccines (4 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
HIV / STI (4 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE · Phase 4 · CAN Community Health
Eye & vision (4 active studies)
- Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) · Phase 4 · Center for Sight Las Vegas
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study · Iantrek, Inc.
Common conditions studied in Las Vegas
- Obesity (20 active studies)
- Overweight (16 active studies)
- Acute Myeloid Leukemia (8 active studies)
- Major Depressive Disorder (7 active studies)
- Schizophrenia (7 active studies)
- Alzheimer Disease (6 active studies)
Leading research sponsors in Las Vegas
- National Cancer Institute (NCI)
- Eli Lilly and Company
- University of Nevada, Las Vegas
- AstraZeneca
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Las Vegas?
There are approximately 411 recruiting clinical trials in Las Vegas, Nevada listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Las Vegas pay participants?
Most recruiting trials in Las Vegas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Las Vegas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Las Vegas?
The most common conditions under active study in Las Vegas include Obesity (20), Overweight (16), Acute Myeloid Leukemia (8), Major Depressive Disorder (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Las Vegas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Las Vegas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Las Vegas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Las Vegas?
Recruiting research sites in Las Vegas include OptumCare Cancer Care at Charleston, OptumCare Cancer Care at Fort Apache, Comprehensive Cancer Centers of Nevada, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Las Vegas right now?
The largest active categories in Las Vegas are Cancer & tumors (100), Diabetes & metabolic (45), Neurology & pain (31). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.